Evidence map›Paper›PMID 42353712›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Tracking Extended-Spectrum β-Lactamase-Producing

Cassandra Klaas, Shawn Hoogstra, David Mahoney, Mark Lubberts, Emil Jurga, Gabriel Wajnberg, Daniella Rizzo, Richard J Reid-Smith, Catherine Carrillo, Rhiannon L Wallace

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cassandra KlaasAgassiz Research and Development Center, Agriculture and Agri-Food Canada, Agassiz, BC V0M 1A0, Canada.ORCID 0009-0000-1941-0569
Shawn HoogstraAgassiz Research and Development Center, Agriculture and Agri-Food Canada, Agassiz, BC V0M 1A0, Canada.ORCID 0000-0003-2533-9310
David MahoneyAgassiz Research and Development Center, Agriculture and Agri-Food Canada, Agassiz, BC V0M 1A0, Canada.ORCID 0000-0002-5732-0959
Mark LubbertsSummerland Research and Development Center, Agriculture and Agri-Food Canada, Summerland, BC V0H 1Z0, Canada.
Emil JurgaNational Microbiology Laboratory, Public Health Agency of Canada, Ottawa, ON K1A 0K9, Canada.
Gabriel WajnbergNational Centre for Animal Disease, Canadian Food Inspection Agency, Lethbridge, AB T1J 5R7, Canada.ORCID 0000-0002-4479-4063
Daniella RizzoCentre for Foodborne, Environment and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON N1G 3W4, Canada.
Richard J Reid-SmithCentre for Foodborne, Environment and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON N1G 3W4, Canada.
Catherine CarrilloOttawa Laboratory (Carling), Canadian Food Inspection Agency, Ottawa, ON K1A 0C6, Canada.ORCID 0000-0002-2334-8718
Rhiannon L WallaceAgassiz Research and Development Center, Agriculture and Agri-Food Canada, Agassiz, BC V0M 1A0, Canada.ORCID 0000-0001-6978-7604

Funding

Government of Canada GRDI-AMR One Health
6 · The paper itself

Abstract

backgroundThe rising prevalence of Extended-spectrum β-lactamase-producing (ESBL)

methodsTo address this, we conducted a longitudinal two-year One Health study to assess ESBL

resultsA total of 546 presumptive ESBL

conclusionsThese findings identify the environment as a reservoir for ESBL

Indexed as

antimicrobial resistance (AMR)Escherichia coliextended-spectrum beta-lactamase (ESBL)Sequence Type 648 (ST648)ST88whole genome sequencing (WGS)

Identifiers

PMID42353712
PMCPMC13295653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.